The Validity of Echocardiographic Measurement of Mean Pulmonary Artery Pressure and Pulmonary Artery Acceleration Time in Assessment of Patients with Pulmonary Hypertension
Sep 2026· Advanced medical journal· Vol 11, pp. 320-329· 0 citations· 24 references
TL;DR
Echocardiography is useful method in screening of pulmonary hypertension by measuring means of pulmonary artery pressure and acceleration time by measuring means of pulmonary artery pressure and acceleration time.
Abstract
Background and Objectives: Echocardiography plays a major role in detection of cardiovascular diseases as low-cost non-invasive method. The aim of this study was to assess the role of echocardiography measurements like pulmonary artery pressure and pulmonary artery acceleration time in diagnosis and severity assessment of pulmonary hypertension.
Methods: An observational cross-sectional study was carried out in Erbil Cardiac Center and Rizgary Teaching Hospital in Erbil City-Kurdistan Region/Iraq within a five-year period from 1st of January, 2019 to 31st of December, 2023 on two hundred patients with pulmonary hypertension. Echocardiography was done by cardiologists. The right-side cardiac catheterization was implemented by interventional cardiologists, mostly pediatric, through the transfemoral vein using a multipurpose catheter.
Results: A highly significant strong positive correlation was observed between echocardiography mean pulmonary artery pressure and mean pulmonary artery pressure measured by right side catheterization (r=0.96, p<0.001). There was a highly significant strong negative correlation between echocardiography mean pulmonary artery acceleration time and mean pulmonary artery pressure measured by right side catheterization (r=0.9, p<0.001).
Conclusions: Echocardiography is useful method in screening of pulmonary hypertension by measuring means of pulmonary artery pressure and acceleration time.
In AdvHF, echocardiographic equations correlate only moderately with invasive PAWP and are not accurate enough for individual-level quantification, so RHC remains indispensable whenever the clinical question is dynamic.
L. Pascalis, V. Nuzzi, Fulvio Perani et al.· The International Journal of...· 0 citations
PURPOSE
Emerging evidence points on an increased mortality risk associated to moderate aortic stenosis (AS), yet this population remains insufficiently characterized. We tested the prognostic value of two echocardiographic coupling indices reflecting right and left-sided cardiac function: the ratio of tricuspid annular...
G. Santangelo, A. Faggiano, G. Mallardi et al.· International Journal of Car...· 0 citations
Recent evidence has demonstrated that transthoracic echocardiography (TTE) can reliably estimate several hemodynamic parameters obtained via right heart catheterization (RHC), paving the way for the so-called "echodynamic approach." Nevertheless, robust prospective validation of this methodology remains lacking....
A. Tripoli, R. Sofia, R. Mazza et al.· European Heart Journal· 0 citations
Despite moderate agreement with PAWP, echocardiography and AI-ECG showed stronger associations with clinical outcomes, suggesting they capture prognostically relevant myocardial information beyond resting hemodynamic status.
G. Tsaban, E. Lee, Francisco López-Jiménez et al.· JACC Cardiovascular Imaging· 0 citations
In patients with acute PE, TAPSE measured at admission in women, but not in men, was the only echocardiographic parameter independently associated with all-cause in-hospital mortality.
Kos Ljiljana, Kovacevic-Preradovic Tamara, Dzudovic Boris et al.· Therapeutic Advances in Resp...· 0 citations
Management of pulmonary arterial hypertension (PAH) is guided by multiparametric risk assessment, integrating clinical, biological, imaging, and hemodynamic parameters. Echocardiographic low-risk features include right atrial (RA) area <18 cm², TAPSE/PASP ratio >0.32 mm/mmHg, and absence of pericardial effusion....
M. El Blidi, T. Duval, É. Artaud-Macari et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.